LakeShore Biopharma Co., Ltd.
Develops vaccines and therapeutic biologics for infectious diseases and cancer.
LSB | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG9845F1090 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- BUILDING NO. 2, 38 YONGDA ROAD, 102629 DAXING DISTRICT, BEIJING
- Website:
- https://www.ysbiopharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
LakeShore Biopharma Co., Ltd. (formerly YS Biopharma) is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of new generations of vaccines and therapeutic biologics. The company focuses on immunology-based biotherapeutics to address infectious diseases and cancer. Its pipeline includes a therapeutic vaccine for hepatitis B and the PIKA Rabies Vaccine, which has announced positive interim results from its pivotal Phase 3 clinical study. The company began trading on the NASDAQ in March 2023.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all LakeShore Biopharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LakeShore Biopharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LakeShore Biopharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
